MedTrace Logo

Interactions Between Drug Effects and Environments II

NCT03075501 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 133

Last updated 2021-05-19

Study results available
· View outcomes & findings →

Summary

The purpose of the study is to determine how associations between drugs and the places where they are experienced influence drug seeking, mood and acute drug responses.

Conditions

  • Substance-Related Disorders

Interventions

BEHAVIORAL

Paired

Drug conditioning is assessed by pairing drug administration with a given context.

DRUG

Stimulant or sedative

CS+ for paired, CS0 for unpaired

DRUG

Placebo

CS- for paired, CS0 for unpaired

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • University of Illinois at Chicago

    lead OTHER

Principal Investigators

  • Emma Childs, PhD · University of Illinois at Chicago

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2020-07-31
Completion
2020-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03075501 on ClinicalTrials.gov